Study Design and Baseline Characteristics of Prespecified, Exploratory Pooled Analysis to Investigate Effect of Finerenone on Cardio-Kidney Outcomes in Patients with CKD and Type 2 Diabetes and/or Heart Failure Shared at Heart Failure 2024 Congress

Baseline characteristics from FINE-HEART analysis highlight complex interplay between cardiovascular, kidney, and metabolic health, with over 92% of patients presenting two or more conditions

Related Keywords

United States ,Lisbon ,Lisboa ,Portugal ,American , ,Us Medical Affairs Cardiovascular ,American Diabetes Association ,American Association Of Clinical Endocrinology ,European Society Of Cardiology ,Drug Administration ,Late Breaking Science Session ,Heart Failure ,European Society ,Robert Perkins ,Vice President ,Kerendia Phase ,American Association ,Clinical Endocrinology ,Kidney Disease ,Improving Global Outcomes ,Prescribing Information ,Chronic Kidney Disease ,